Book Value per Share: MiMedx Group, Inc. (MDXG)

Graphic logo of MiMedx Group, Inc. (MDXG)

MiMedx Group, Inc. (MDXG) specializes in the development of placental biomaterials for tissue regeneration. This chart captures the asset's price action, where the indicator stands at 1.48. The expanded application of products in orthopedics and surgery minimizes industry risks. A steady cash flow is driven by robust clinic demand for wound-healing drugs, confirming the business's high operational efficiency.

MiMedx Group Inc (MDXG): Share Book Value from 07/04/2022 to 10/27/2026

mimedx.com - analytical breakdowns and key metrics (MDXG)

- price and consensus price forecast:
Stock Quotes MiMedx Group|MDXG - Broker Consensus Forecast
- market capitalization data:
Market Capitalization MiMedx Group, Inc.|MDXG - Full Takeover Company Value
- book capitalization data:
Net Assets per Single Share MiMedx|MDXG - Net Asset Value|Market Capitalization to Book Value Ratio mimedx.com|MDXG - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital MiMedx Group, Inc.|MDXG - Long-Term Debt to Capital|Short-Term Debt to Equity MiMedx|MDXG - Aggregate Debt Obligations|Debt to Book Capitalization Ratio MiMedx Group, Inc.
Fundamental company valuation:MiMedx Group - MDXG
Manufactured products of MiMedx

Operational efficiency directly impacts net asset dynamics, determining the intrinsic value of the business. This indicator measures the actual capital per share, excluding market speculation. For MiMedx Group, Inc. (MDXG), this calculation is supported by sterilization and biomaterial disposal costs. The optimization of such production processes directly shapes the final capital. By analyzing the current book value per share, an investor can assess the fundamental stability of the company.

Competitors of MiMedx Group, Inc. (MDXG)

Ascendis Pharma Inc. (ASND) - Accounting Value per Share|MDGL - Equity per Share|Book Value per Share CORT (Corcept Therapeutics)|RYTM (rhythmtx.com) - Book Value of One Share|Net Assets per Single Share Akero AKRO|Share Book Value Metsera, Inc.|MoonLake Pharma (MLTX) - Book Value per Share|Accounting Value of a Share Crinetics Corp (CRNX)|Book Value per Share NAMS (NewAmsterdam Pharma)|soleno.life - Book Value per Share|Net Assets per Single Share Amicus Therapeutics, Inc. (FOLD)|ETNB: Accounting Value of a Share|AGIO (Agios Pharmaceuticals Inc) - Net Assets per Single Share|Structure Corp (GPCR) - Accounting Value per Share|RZLT (Rezolute, Inc.) - Book Value per Share|Book Value per Share lexpharma.com (LXRX)|MBX Biosciences (MBX) - Accounting Value per Share|Accounting Value of a Share ALT (Altimmune Inc)|Aardvark Therapeutics Corp - Net Assets per Single Share|Accounting Value per Share Sagimet Biosciences Inc SGMT|BIOA (BioAge Labs, Inc.) - Book Value per Share|biomeafusion.com (BMEA) - Net Asset Value per Share|QNCX - Accounting Value per Share|Fractyl Health Inc. (GUTS) - Book Price of a Share|VTVT (vTv Therapeutics, Inc.) - Book Value per Share|Book Value per Share Agape ATP Corp.|Book Value per Share Pluri Inc. (PLUR)|Net Assets per Single Share SYBX (synlogictx.com)|LPCN: Net Assets per Single Share|Matinas BioPharma Holdings, Inc. - Net Asset Value per Share|SPRB - Net Assets per Single Share|GLTO - Net Assets per Single Share|Carmell Corporation - Book Value per Share|LUMO (lumos-pharma.com) - Net Assets per Share|ONVO: Net Assets per Single Share|Net Assets per Share RDUS